Fueling Innovation with Non-Dilutive Funding
JP Morgan Healthcare Conference
January 14, 202612pm - 5pm PT
Metropolitan Club
Grant Engine @ JPM 2026 – Fueling Innovation with Non-Dilutive Funding
This event aligns Grant Engine’s mission with the most prestigious healthcare capital markets conference in the world. As we convene in San Francisco, our goal is to drive industry-shaping discussions, showcase funding success stories, and build pathways between non-dilutive capital, equity investment, and scalable growth.
Date: January 14, 2026
Time: 12pm-5pm PT; Reception to Follow
Location: Metropolitan Club, 640 Sutter St, San Francisco, CA 94102
This year, our participation includes a series of curated sessions:
-
Funding Market Overview: Insights into 2026 funding trends, including NIH, DoD, ARPA-H, DARPA, and BARDA—with an emphasis on strategic planning under the current administration. BREAKING NEWS: We've expanded our ARPA-H lineup to be a fireside chat with three key individuals: Acting Director of the Scalable Solutions Mission Office, and two Program Managers to get closer to the action of how to interact with PMs and the Agency to dramatically improve your alignment and win rate with specific programs of interest.
-
Funding Agency Presentations: Sessions featuring key government representatives outlining upcoming funding opportunities and how to access them.
-
Client Case Studies: Real-world success stories from companies that have won $5M+ in non-dilutive funding with Grant Engine’s support.
-
Venture Investor Reverse Pitch (New!): In a flipped format, venture investors and strategics will present what they are looking to fund in biotech. This unique format connects innovators directly with capital.
-
One-on-One Meetings: Confidential meetings between clients and target agencies or investors. This is where real deals are shaped. Meetings will be facilitated through Grant Engine’s calendaring system.
Audience:
-
Biotech and healthtech company executives
-
Government agency leaders
-
Venture capital and strategic investors
-
Current and prospective Grant Engine clients
Schedule
-
12:00 - 12:30pm
Sam Tetlow (Founder and CEO, Grant Engine)
-
12:30 - 1:00pm
Joe Piper (Executive Chairman and founder, PatchClamp MedTech)
-
1:00 - 1:30pm
Sunil Gandhi, Ph.D. (Founder & CEO, Savanna Biosciences)
-
1:30 - 2:00pm
Sam Wu, MD Ph.D (General Partner, 7G BioVentures)
-
2:00 - 2:30pm Fireside Chat
Sam Tetlow (Founder and CEO, Grant Engine)
Natalie Kates (Acting Director, Scalable Solutions, ARPA-H)
Gloria Elliott, Ph.D (Program Manager, Scalable Solutions, ARPA-H)
Erika Kim, Ph.D. (Program Manager, Resilient Systems, ARPA-H)
-
2:30 - 3:00pm
Dave Messina (General Partner, Pioneer Funds)
-
3:00 - 3:30pm
Brian Fiske, Ph.D (Chief Scientist, Michael J. Fox Foundation)
-
3:30 - 4:00pm
Lazar Bojic, Ph.D (VP, Investor Network, Curie.Bio)
-
4:00 - 4:30pm
Dr. Ken Smith, Ph.D (Chief Product Development Officer, CPRIT)
-
4:30 - 5:00pm
Dr. Nakela L. Cook, M.D., MPH (Executive Director, PCORI)
Featured Speakers
.png "Advanced Research Projects Agency for Health (ARPA-H)")
Natalie Kates
Acting Director, Scalable Solutions
Gloria Elliott, Ph.D.
Program Manager, Scalable Solutions
Erika Kim, Ph.D.
Program Manager, Resilient Systems
Brian Fiske, PhD
Chief Scientist
Dr. Ken Smith, PhD
Chief Product Development Officer
Dave Messina
General Partner
Lazar Bojic, PhD
VP, Investor
Nakela L. Cook, M.D., MPH
Sam Wu, MD PhD
Partner
Joe Piper
Executive Chairman, Founder, DIRECTOR
Sunil Gandhi, PhD
Founding Chief Technology Officer
Testimonials
A few words from grant-winning Grant Engine customers
“We're thrilled to say that our partnership with Grant Engine has been an extraordinary success. Grant Engine provided us with a solution that helped us secure funding for our project We've won 4 NIH SBIR Phase I grants with Grant Engine so far and anticipate more to come. We would highly recommend the services of Grant Engine to others looking for non-dilutive funding!” - Joshua Yang; Co-Founder and CEO; Glyphic Biotechnologies
“The fit was perfect as the Grant Engine team was quick to understand our technology and our value proposition and facilitated the process of translating our passion and vision into a well-written and well-received SBIR application. We will be working with them in the future as we expand upon our quest for additional non-dilutive funding." - David Dolinger; Vice President of Product Management and Quality; General Fluidics
“If you're a life science or medical technology company, you know the struggle to obtain funding. Grant Engine was able to help us win a large FDA award for our research and development efforts, which will help us continue our work in the field. They helped us with every step of the process, from understanding our business model and needs to craft an application that would appeal to funders." - Jesse O'Gorman; President; Safe Health Systems